Human T lymphocytes possess both the type I and II isozymes of protein kinase A (PKA). The type I (PKA-I) isozyme is predominantly associated with the plasma membrane, whereas the type II (PKA-II) isozyme is primarily localized to the cytosol. Because the functions of both PKA-I and PKA-II isozymes in the biochemical events of T lymphocyte activation have not been clearly elucidated, we tested the hypothesis that very early events of normal human T lymphocyte activation are mediated by the PKA-I and/or PKA-II isozyme(s). Fresh normal human T cells and a normal human CD4+ T cell line (GK606) activated with anti-CD3-epsilon and recombinant interleukin 1 alpha (rIL-1 alpha) exhibited a peak six- to sevenfold increase of PKA phosphotransferase activity at 5 min that returned to baseline by 60 min. Similarly, both fresh T cells and the T cell line activated by phorbol myristate acetate and ionomycin demonstrated a peak eightfold increase of PKA activity by 15 min that returned toward baseline by 60 min. Chromatographic separation of the PKA isozymes and quantification of phosphotransferase activities after T cell activation by either agonist pair showed preferential activation of the PKA-I isozyme, resulting in a significant reduction in the ratio of PKA-I to PKA-II isozyme activity from 3.1:1-6.2:1 to 1.1:1-3.2:1. PKA-I isozyme activation resulted in the release of free catalytic (C) subunit, an increase in C subunit phosphotransferase activity, and the phosphorylation of T cell plasma membrane-associated proteins, p14, p17, p20, p21, p38, and p48. However, activation of the PKA-I isozyme did not appear to be required for the transcription of IL-2 mRNA, an event necessary for mitosis. These data indicate that ligand-induced T cell activation is associated with rapid activation of the PKA-I, but not PKA-II, isozyme that results in phosphorylation of plasma membrane-associated proteins. The involvement of the PKA-I isozyme during the very early events of T cell activation suggests that this isozyme may be an antigen- or mitogen-stimulated protein kinase.
D Laxminarayana, A Berrada, G M Kammer
Title and authors | Publication | Year |
---|---|---|
Lupus
WA Khan |
Lupus | 2017 |
Regulation of T cells in airway disease by beta-agonist
MJ Loza, RB Penn |
Frontiers in bioscience (Scholar edition) | 2010 |
Induction of 150-kDa adenosine deaminase that acts on RNA (ADAR)-1 gene expression in normal T lymphocytes by anti-CD3-epsilon and anti-CD28
D Laxminarayana, IU Khan, KS O'Rourke, B Giri |
Immunology | 2007 |
Beta-agonists modulate T-cell functions via direct actions on type 1 and type 2 cells
MJ Loza, S Foster, SP Peters, RB Penn |
Blood | 2006 |
MECHANISMS OF DEFICIENT TYPE I PROTEIN KINASE A ACTIVITY IN LUPUS T LYMPHOCYTES
GM Kammer, D Laxminarayana, IU Khan |
International Reviews of Immunology | 2004 |
T cell receptor induced intracellular redistribution of type I protein kinase A
W Zhou, L Vergara, R König |
Immunology | 2004 |
Down-Regulation of IL-2 Production in T Lymphocytes by Phosphorylated Protein Kinase A-RIIβ
MR Elliott, RA Shanks, IU Khan, JW Brooks, PJ Burkett, BJ Nelson, V Kyttaris, YT Juang, GC Tsokos, GM Kammer |
Journal of immunology (Baltimore, Md. : 1950) | 2004 |
HA1004, an inhibitor of serine/threonine protein kinases, restores the sensitivity of thymic lymphomas to Ca2+-mediated apoptosis through a protein kinase A-independent mechanism
J Matuszyk, M Cebrat, W Kalas, L Strzadala |
International Immunopharmacology | 2002 |
Commitment of Activated T Cells to Secondary Responsiveness Is Enhanced by Signals Mediated by cAMP-Dependent Protein Kinase A-I
M Vig, A George, R Sen, J Durdik, S Rath, V Bal |
Molecular pharmacology | 2002 |
Protein Kinase A RIβ Subunit Deficiency in Lupus T Lymphocytes: Bypassing a Block in RIβ Translation Reconstitutes Protein Kinase A Activity and Augments IL-2 Production
IU Khan, D Laxminarayana, GM Kammer |
Journal of immunology (Baltimore, Md. : 1950) | 2001 |
Generation of stable cell lines by spontaneous immortalization of primary cultures of porcine granulosa cells
C Gillio-Meina, CL Swan, NK Crellin, DM Stocco, PJ Chedrese |
Molecular Reproduction and Development | 2000 |
Molecular aberrations in human systemic lupus erythematosus
GC Tsokos, GM Kammer |
Molecular Medicine Today | 2000 |
mRNA mutations of type I protein kinase A regulatory subunit α in T lymphocytes of a subject with systemic lupus erythematosus
D Laxminarayana, GM Kammer |
International Immunology | 2000 |
Association of Deficient Type II Protein Kinase A Activity with Aberrant Nuclear Translocation of the RIIβ Subunit in Systemic Lupus Erythematosus T Lymphocytes
N Mishra, IU Khan, GC Tsokos, GM Kammer |
Journal of immunology (Baltimore, Md. : 1950) | 2000 |
Targeting of epidermal growth factor receptor and protein kinase A: Molecular basis and therapeutic applications
G Tortora, F Ciardiello |
Annals of Oncology | 2000 |
Beta-adrenergic receptor agonists and cyclic nucleotide phosphodiesterase inhibitors: shifting the focus from inotropy to cyclic adenosine monophosphate
MA Movsesian |
Journal of the American College of Cardiology | 1999 |
Antisense Therapeutics in Oncology: Points to Consider in Their Clinical Evaluation
S Mani, Y Gu, S Wadler, H Fingert |
Antisense and Nucleic Acid Drug Development | 1999 |
High prevalence of T cell type I protein kinase a deficiency in systemic lupus erythematosus
GM Kammer |
Arthritis & Rheumatism | 1999 |
Effect of PGE2 on the cell surface molecule expression in PMA treated thymocytes
R Daculsi, D Vaillier, JC Carron, N Gualde |
Immunology Letters | 1998 |
Protein kinase A type I antagonist restores immune responses of T cells from HIV-infected patients
EM Aandahl, P Aukrust, BS Skålhegg, F Müller, SS Frøland, V Hansson, K Taskén |
The FASEB Journal | 1998 |
Regulation of adenylyl cyclase activity in human peripheral blood mononuclear cells: effects of protein kinase inhibitors and of a calcium ionophore
HA Buc, A Moncion, JL Pérignon |
International Journal of Immunopharmacology | 1998 |
Co-regulation of antigen-specific t lymphocyte responses by type i and type ii cyclic amp-dependent protein kinases (cak)
CM Braun, SK Huang, A Kagey-Sobotka, LM Lichtenstein, DM Essayan |
Biochemical Pharmacology | 1998 |
Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane
IU Khan, R Wallin, RS Gupta, GM Kammer |
Proceedings of the National Academy of Sciences | 1998 |
Protein kinase A-catalyzed phosphorylation of heat shock protein 60 chaperone regulates its attachment to histone 2B in the T lymphocyte plasma membrane.
Khan IU, Wallin R, Gupta RS, Kammer GM |
Proceedings of the National Academy of Sciences | 1998 |
Transient CRE- and κB site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes
WS Koh, YJ Jeon, AC Herring, NE Kaminski |
Life Sciences | 1997 |
Inhibition of protein kinase A and cyclic AMP response element (CRE)-specific transcription factor binding by Δ9-tetrahydrocannabinol (Δ9-THC)
WS Koh, RB Crawford, NE Kaminski |
Biochemical Pharmacology | 1997 |
Serotonin Modulates Immune Function in T Cells from HIV-Seropositive Subjects
J Eugen-Olsen, P Afzelius, L Andresen, J Iversen, G Kronborg, P Aabech, JO Nielsen, B Hofmann |
Clinical Immunology and Immunopathology | 1997 |
Analysis of the in vitro effect of exogenous nitric oxide on human lymphocytes
A S Shoker, H Yang, M A Murabit, H Jamil, A al-Ghoul, K Okasha |
Molecular and Cellular Biochemistry | 1997 |
Inhibition of human lymphocyte function by organic solvents
A S Shoker, M A Murabit, F F Georges, L F Qualtiere, H G Deneer, K Prasad |
Molecular and Cellular Biochemistry | 1997 |
The T cell enigma in lupus
AK Dayal, GM Kammer |
Arthritis & Rheumatism | 1996 |
Regulation of interferon-γ mRNA in a cytolytic T cell clone: Ca2+-induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP
P Kaldy, AM Schmitt-Verhulst |
European Journal of Immunology | 1995 |
Immunosuppressive retroviral peptides: cAMP and cytokine patterns
S Haraguchi, RA Good, NK Day |
Immunology Today | 1995 |
Ion Channels in Inexcitable Cells
H Sontheimer |
The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry | 1995 |
Deficient type I protein kinase A isozyme activity in systemic lupus erythematosus T lymphocytes
GM Kammer, IU Khan, CJ Malemud |
Journal of Clinical Investigation | 1994 |